Table 2 Multivariable Cox analysis for all-cause mortality

HbA1c-SD (high, low)

1.649

1.288–2.110

< 0.001

–

–

–

HbA1c-CV (high, low)

–

–

–

1.558

1.216–1.997

< 0.001

E/e′

1.069

1.015–1.125

0.011

1.063

1.010–1.119

0.019

LVEF (≥ 50, 40–49, < 40%)

1.159

1.003–1.340

0.045

1.178

1.019–1.362

0.021

Age

1.014

0.997–1.030

0.109

1.014

0.997–1.031

0.104

eGFR

0.990

0.977–1.003

0.142

0.989

0.976–1.003

0.115

ACEI/ARB

0.705

0.526–0.945

0.019

0.701

0.523–0.940

0.018

Beta-blocker

0.738

0.564–0.965

0.026

0.719

0.549–0.941

0.016

BNP (tertiles)

1.335

1.146–1.555

< 0.001

1.317

1.131–1.534

< 0.001

Ischemic HF

1.076

0.846–1.370

0.550

1.067

0.838–1.359

0.598

NYHA

1.103

0.994–1.287

0.217

1.019

0.949–1.296

0.191

Gender

1.098

0.849–1.421

0.475

1.111

0.859–1.438

0.423

Baseline HbA1c

1.045

0.850–1.285

0.674

1.036

0.843–1.274

0.733

Number of HbA1c measurements

1.034

0.974–1.098

0.277

1.030

0.970–1.094

0.332

HbA1c-mean

1.085

0.895–1.315

0.406

1.191

0.979–1.449

0.080